Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Gu, Jin Gang ^a   Zhu, Cheng Liang ^b   Cheng, Duo Zhi ^c   Xie, Yan ^a   Liu, Fang ^a   Zhou, Xin ^a  

^a WUHAN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c Taihe Hospital of Hubei Medical College   (China)

Author keywords

Apolipoprotein M; ELISA; Hepatitis B virus; Replication; RT PCR

Indexed keywords

APOLIPOPROTEIN M; MESSENGER RNA; PROTEIN S; VIRUS DNA; APOLIPOPROTEIN; APOM PROTEIN, HUMAN; LIPOCALIN; RENILLA LUCIFERIN 2 MONOOXYGENASE; VIRUS PROTEIN;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS REPLICATION; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CELL STRAIN HEPG2; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; PROMOTER REGION; REPORTER GENE;

HEPATITIS B VIRUS;

APOLIPOPROTEINS; CASE-CONTROL STUDIES; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; HEP G2 CELLS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIPOCALINS; LUCIFERASES, RENILLA; PROMOTER REGIONS, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 80052090517     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-154     Document Type: Article

References (29)

1. Engineering immune therapy against hepatitis B virus. F Akbar, O Yoshida, M Abe, Y Hiasa, M Onji, Hepatol Res 2007 37 Suppl 3 351 356 17931186
2. Hepatitis B, hepatocellular carcinoma, and strategies for prevention. MJ Arthur, AJ Hall, R Wright, Lancet 1984 1 8377 607 610 6142315 (Pubitemid 14156522)
3. Hepatitis B virus. The major etiology of hepatocellular carcinoma. RP Beasley, Cancer 1988 61 10 1942 1956 10.1002/1097-0142(19880515)61:10<1942:: AID-CNCR2820611003>3.0.CO;2-J 2834034
4. Hepatitis B virus and the prevention of primary hepatocellular carcinoma. BS Blumberg, WT London, N Engl J Med 1981 304 13 782 784 10.1056/ NEJM198103263041312 6258074 (Pubitemid 11153774)
5. The immune response during hepatitis B virus infection. A Bertoletti, AJ Gehring, J Gen Virol 2006 87 Pt 6 1439 1449 16690908 (Pubitemid 43827198)
6. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? A Bertoletti, MK Maini, Curr Opin Microbiol 2000 3 4 387 392 10.1016/S1369-5274(00)00109-0 10972499 (Pubitemid 30640363)
7. The immune response induced by hepatitis B virus principal antigens. CF Huang, SS Lin, YC Ho, FL Chen, CC Yang, Cell Mol Immunol 1111 3 2 97 106
8. Immune system and hepatitis B virus infection. CK Hui, GK Lau, J Clin Virol 2005 34 Suppl 1 44 48 16461223
9. A novel human apolipoprotein (apoM). N Xu, B Dahlback, J Biol Chem 1999 274 44 31286 31290 10.1074/jbc.274.44.31286 10531326 (Pubitemid 29508486)
10. Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis. J Duan, B Dahlback, BO Villoutreix, FEBS Lett 2001 499 1-2 127 132 10.1016/S0014-5793(01)02544-3 11418126 (Pubitemid 32539335)
11. Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M. J Ahnstrom, K Faber, O Axler, B Dahlback, J Lipid Res 2007 48 8 1754 1762 10.1194/jlr.M700103-JLR200 17525477 (Pubitemid 47311992)
12. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. J Diao, R Garces, CD Richardson, Cytokine Growth Factor Rev 2001 12 2-3 189 205 10.1016/S1359-6101(00)00034-4 11325602 (Pubitemid 32588145)
13. Hepatitis B virus × antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. MA Feitelson, LX Duan, Am J Pathol 1997 150 4 1141 1157 9094970 (Pubitemid 27152632)
14. Modulation of intracellular signal transduction pathways by the hepatitis B virus transactivator pX. G Natoli, ML Avantaggiati, P Chirillo, E De Marzio, D Collepardo, M Falco, C Balsano, M Levrero, J Hepatol 1995 22 1 Suppl 14 20 7602067
15. Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro. C Zhu, R Zhang, L Liu, ST Rasool, Y Mu, W Sun, Q Hao, F Liu, Y Zhu, J Wu, Clin Immunol 2009 131 1 92 97 10.1016/j.clim.2008.10.011 19081304
16. Borna disease virus P protein inhibits nitric oxide synthase gene expression in astrocytes. G Peng, F Zhang, Q Zhang, K Wu, F Zhu, J Wu, Virology 2007 366 2 446 452 10.1016/j.virol.2007.04.031 17543364 (Pubitemid 47390999)
17. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. C Nobile, C Petit, A Moris, K Skrabal, JP Abastado, F Mammano, O Schwartz, J Virol 2005 79 9 5386 5399 10.1128/JVI.79.9.5386-5399.2005 15827153 (Pubitemid 40548207)
18. Plasma concentrations of apolipoproteins A-I, B, and M in patients with critical limb ischemia. J Ahnstrom, A Gottsater, B Lindblad, B Dahlback, Clin Biochem 2010 43 6 599 603 10.1016/j.clinbiochem.2010.01.001 20080084
19. Plasma concentrations of apolipoproteins A-I, B and M in patients with abdominal aortic aneurysms. J Ahnstrom, A Gottsater, B Lindblad, B Dahlback, Clin Biochem 2010 43 4-5 407 410 10.1016/j.clinbiochem.2009.11.006 19932694
20. An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma. O Axler, J Ahnstrom, B Dahlback, J Lipid Res 2007 48 8 1772 1780 10.1194/jlr.M700113-JLR200 17526892 (Pubitemid 47311994)
21. Prevention of mortality from hepatitis B and hepatitis C. ER Schiff, Lancet 2006 368 9539 896 897 10.1016/S0140-6736(06)69347-1 16962862 (Pubitemid 44331366)
22. Hepatitis B virus infection - natural history and clinical consequences. D Ganem, AM Prince, N Engl J Med 2004 350 11 1118 1129 10.1056/NEJMra031087 15014185 (Pubitemid 38298992)
23. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. C Ferrari, A Penna, A Bertoletti, A Valli, AD Antoni, T Giuberti, A Cavalli, MA Petit, F Fiaccadori, J Immunol 1990 145 10 3442 3449 2230128
24. Apolipoprotein M - a novel player in high-density lipoprotein metabolism and atherosclerosis. B Dahlback, LB Nielsen, Curr Opin Lipidol 2006 17 3 291 295 10.1097/01.mol.0000226122.10005.88 16680035 (Pubitemid 43786064)
25. Apolipoprotein M: progress in understanding its regulation and metabolic functions. C Christoffersen, B Dahlback, LB Nielsen, Scand J Clin Lab Invest 2006 66 7 631 637 10.1080/00365510600885500 17101555 (Pubitemid 44764397)
26. Expression pattern of apolipoprotein M during mouse and human embryogenesis. XY Zhang, GQ Jiao, M Hurtig, X Dong, L Zheng, GH Luo, P Nilsson-Ehle, Q Ye, N Xu, Acta Histochem 2004 106 2 123 128 10.1016/j.acthis. 2003.11.004 15147633 (Pubitemid 41115134)
27. Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization. XY Zhang, X Dong, L Zheng, GH Luo, YH Liu, U Ekstrom, P Nilsson-Ehle, Q Ye, N Xu, Acta Histochem 2003 105 1 67 72 10.1078/0065-1281-00687 12666989 (Pubitemid 36313933)
28. Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases. J Jiang, X Zhang, C Wu, X Qin, G Luo, H Deng, M Lu, B Xu, M Li, M Ji, N Xu, Lipids Health Dis 2008 7 25 10.1186/1476-511X-7-25 18652652
29. Expression of apolipoprotein M in human hepatocellular carcinoma tissues. J Jiang, C Wu, G Luo, L Zheng, L Chen, X Zhang, N Xu, Acta Histochem 2009 29